CLS’s acting CEO Dan J. Mogren will go on a planned sick leave
Clinical Laserthermia Systems AB (publ) (CLS), which develops advanced innovative products for high-precision image guided laser ablation, announces that its acting CEO Dan J. Mogren will go on a planned sick leave on Feb 10th until the March 31st. The Board of Directors has appointed Lars-Erik Eriksson, the company CFO and previous CEO, deputy CEO during this period.“I will undergo a routine heart valve replacement procedure that requires open surgery and therefore demands some weeks of healing for full recovery. I hoped for the possibility of a minimally invasive procedure but